Ascendis Pharma A/S (asnd 2.25 04/01/28)
13F holders, Q2 2024 (June 30)3holders
1new positions
1sold out
$2.06avg. 13F price*
At the end of Q2 2024, 3 institutions reported holding Ascendis Pharma A/S (asnd 2.25 04/01/28) in their 13F filings, unchanged from Q1 2024. 1 opened new positions and 1 sold out. The largest holders were BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.2M), Loomis Sayles & Co. L P ($2.0M) and Jane Street Group, LLC ($110K).
- Company
- Ascendis Pharma A/S (asnd 2.25 04/01/28)
- CUSIP
- 04351PAD3
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2.0M |
| Exits | 1 | $6.9M |
All 13F filers, Q1 2024 → Q2 2024: 14,909 shares bought and 256,000 shares sold, net −241,091 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | No change | 2,000,000 | $2.2M |
| Loomis Sayles & Co. L P | 0.00% | New | 14,909 | $2.0M |
| Jane Street Group, LLC | 0.00% | Reduce -71.4% | 100,000 | $110K |
"% of holder's portfolio" is ASCENDIS PHARMA A/S (ASND 2.25 04/01/28)'s weight in each manager's 13F, not the share of Ascendis Pharma A/S (asnd 2.25 04/01/28) the manager owns.